These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15661527)

  • 1. Mutational analysis of gene families in human cancer.
    Bardelli A; Velculescu VE
    Curr Opin Genet Dev; 2005 Feb; 15(1):5-12. PubMed ID: 15661527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput mutational analysis of the human cancer genome.
    Ma PC; Zhang X; Wang ZJ
    Pharmacogenomics; 2006 Jun; 7(4):597-612. PubMed ID: 16753007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analyses of the cancer genome: lessons learned from sequencing most of the annotated human protein-coding genes.
    Sjöblom T
    Curr Opin Oncol; 2008 Jan; 20(1):66-71. PubMed ID: 18043258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN mutations are common in sporadic microsatellite stable colorectal cancer.
    Nassif NT; Lobo GP; Wu X; Henderson CJ; Morrison CD; Eng C; Jalaludin B; Segelov E
    Oncogene; 2004 Jan; 23(2):617-28. PubMed ID: 14724591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cancer genes by mutational profiling of tumor genomes.
    Benvenuti S; Arena S; Bardelli A
    FEBS Lett; 2005 Mar; 579(8):1884-90. PubMed ID: 15763568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the ARAF gene in human cancers.
    Lee JW; Soung YH; Kim SY; Park WS; Nam SW; Min WS; Kim SH; Lee JY; Yoo NJ; Lee SH
    APMIS; 2005 Jan; 113(1):54-7. PubMed ID: 15676015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
    Zhou XP; Loukola A; Salovaara R; Nystrom-Lahti M; Peltomäki P; de la Chapelle A; Aaltonen LA; Eng C
    Am J Pathol; 2002 Aug; 161(2):439-47. PubMed ID: 12163369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput oncogene mutation profiling in human cancer.
    Thomas RK; Baker AC; Debiasi RM; Winckler W; Laframboise T; Lin WM; Wang M; Feng W; Zander T; MacConaill L; Lee JC; Nicoletti R; Hatton C; Goyette M; Girard L; Majmudar K; Ziaugra L; Wong KK; Gabriel S; Beroukhim R; Peyton M; Barretina J; Dutt A; Emery C; Greulich H; Shah K; Sasaki H; Gazdar A; Minna J; Armstrong SA; Mellinghoff IK; Hodi FS; Dranoff G; Mischel PS; Cloughesy TF; Nelson SF; Liau LM; Mertz K; Rubin MA; Moch H; Loda M; Catalona W; Fletcher J; Signoretti S; Kaye F; Anderson KC; Demetri GD; Dummer R; Wagner S; Herlyn M; Sellers WR; Meyerson M; Garraway LA
    Nat Genet; 2007 Mar; 39(3):347-51. PubMed ID: 17293865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide mutational analyses of breast and colorectal cancers.
    Lin J; Sjöblom T
    Discov Med; 2007 Feb; 7(37):13-9. PubMed ID: 17343800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphatases as a superfamily of tumor suppressors in colorectal cancer.
    Laczmanska I; Sasiadek MM
    Acta Biochim Pol; 2011; 58(4):467-70. PubMed ID: 22146137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the blueprint of the cancer genome.
    Velculescu VE
    Carcinogenesis; 2008 Jun; 29(6):1087-91. PubMed ID: 18495658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinase mutations in human disease: interpreting genotype-phenotype relationships.
    Lahiry P; Torkamani A; Schork NJ; Hegele RA
    Nat Rev Genet; 2010 Jan; 11(1):60-74. PubMed ID: 20019687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
    Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
    N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer genomics in post-sequence era].
    Inazawa J
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():42-9. PubMed ID: 16416769
    [No Abstract]   [Full Text] [Related]  

  • 16. Somatic BRAF-V600E mutations in familial colorectal cancer.
    Vandrovcova J; Lagerstedt-Robinsson K; Påhlman L; Lindblom A
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations truncating the EP300 acetylase in human cancers.
    Gayther SA; Batley SJ; Linger L; Bannister A; Thorpe K; Chin SF; Daigo Y; Russell P; Wilson A; Sowter HM; Delhanty JD; Ponder BA; Kouzarides T; Caldas C
    Nat Genet; 2000 Mar; 24(3):300-3. PubMed ID: 10700188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative Real Common Target genes.
    Woerner SM; Benner A; Sutter C; Schiller M; Yuan YP; Keller G; Bork P; Doeberitz Mv; Gebert JF
    Oncogene; 2003 Apr; 22(15):2226-35. PubMed ID: 12700659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic alterations in the human cancer genome.
    Weir B; Zhao X; Meyerson M
    Cancer Cell; 2004 Nov; 6(5):433-8. PubMed ID: 15542426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.